Sign in
Taking people in United StatesNo phase

Corticosteroid shots versus platelet-rich plasma shots for shoulder joint osteoarthritis

Compares corticosteroid and platelet-rich plasma injections for shoulder osteoarthritis in adults.

Key facts

Who runs it
Rush University Medical Center
Where
Chicago, United StatesSee the site
Trial code
Registry title
Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)
Status
Recruiting
People taking part
200 people, planned
Started
13 Mar 2023
Expected to end
Jan 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Glenohumeral Injection
Record updated
17 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with primary osteoarthritis of the shoulder joint and moderate or worse pain. It compares steroid injections with platelet-rich plasma (PRP) injections into the shoulder.

Age
18 years or older
Sex
All sexes
Disease stage
Primary glenohumeral (shoulder joint) arthritis, bone on bone or near bone on bone, diagnosed earlier on X-rays and by a doctor's exam. Pain level above 4 on the VAS pain scale.
Earlier treatment
No surgery on the same shoulder within 1 year. No injection into the shoulder joint within 3 months.

Main reasons for not taking part

  • Arthritis from another cause, such as infection, rheumatoid arthritis, rotator cuff damage or injury
  • Allergy to lidocaine
  • Known pregnancy
  • A workers compensation case about the shoulder
  • Shoulder surgery on the same side within 1 year, or a shoulder joint injection within 3 months

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patient ≥18y.o. of age
  • Primary glenohumeral arthritis (bone on bone or near bone on bone) that has been previously diagnosed on radiographs and clinical evaluation
  • Baseline pain level of VAS >4

Who cannot take part

  • Ipsilateral shoulder surgery within 1 year
  • Allergy to lidocaine
  • Secondary causes of arthritis (i.e. septic arthritis, rheumatoid arthritis, rotator cuff arthropathy, post-traumatic arthritis)
  • Any glenohumeral joint injection within 3 months
  • Known pregnancy
  • Workers compensation case regarding shoulder

Where in United States

  • Rush University Medical CenterChicago, United StatesContact: Carla M Edwards, PhDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of glenohumeral OA is not known, yet these treatments are commonly used with hopes of providing patients with symptomatic relief that can hopefully delay or prevent the need for shoulder arthroplasty. This study will help elucidate the therapeutic benefit of corticosteroid and Platelet Rich Plasma (PRP) injections in this patient population.

The 2 groups in the trial

  • Corticosteroid Injection GroupTreatment being tested

    80mg Depo-Medrol and 8cc Lidocaine ultrasound-guided intra-articular injection

    Treatment: Glenohumeral Injection

  • Platelet-Rich Plasma Injection GroupExisting treatment, for comparison

    15cc blood draw in Arthrex Autologous Conditioned Plasma (ACP) kit and processed per manufacturer instructions Ultrasound-guided intra-articular injection of isolated PRP

    Treatment: Glenohumeral Injection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective, Double Blind, Randomized Control Trial Comparing the Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis
Plain-language title
Corticosteroid shots versus platelet-rich plasma shots for shoulder joint osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 February 2026